Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Grindr Director Sells 500,000 Shares in Two-Day Trade

George Raymond Zage III, a director and 10% owner of Grindr Inc. (NYSE:GRND), filed a Form 4 on September 18, 2026, disclosing the sale of 500,000 shares of common stock across two transactions on September 16 and September 17, 2026, pursuant to a Rule …

Aakashdeep | 18 September 2026

Scholastic Corp Director Receives RSU Grant

Director Alix Guerrier filed a Form 4 with the SEC on September 18, 2026, reporting the acquisition of restricted stock units in Scholastic Corporation on September 16, 2026.

Anjali Anand | 18 September 2026

Scholastic Corp Director Linda Li Receives RSU Grant

Director Linda Li filed a Form 4 with the SEC on September 18, 2026, disclosing the acquisition of 3,700 restricted stock units of Scholastic Corporation on September 16, 2026.

Shwetambri Chauhan | 18 September 2026

United Therapeutics CEO Sells Shares Under 10b5-1 Plan

Martine A. Rothblatt, Chairperson and CEO of United Therapeutics Corp (NASDAQ:UTHR), filed a Form 4 on September 18, 2026, disclosing the exercise of stock options and sale of common stock on September 17, 2026, pursuant to a pre-arranged Rule 10b5-1 trading plan.

Manish Choudhary | 18 September 2026

United Therapeutics EVP Exercises Options, Sells Shares

Paul A. Mahon, EVP and General Counsel of United Therapeutics Corp (NASDAQ:UTHR), filed a Form 4 on September 18, 2026, disclosing the exercise of 8,300 stock options and the sale of 8,300 shares of common stock on September 17, 2026, pursuant to a pre-arranged …

Aakashdeep | 18 September 2026

American Battery Technology COO Reports Share Vesting and Tax Sale

Steven Wu, Chief Operating Officer of American Battery Technology Co, filed a Form 4 on September 18, 2026, disclosing two transactions in the company's common stock that occurred on September 16 and September 17, 2026.

Aditi Sarkar | 18 September 2026

Harmony Biosciences CMO Exercises Options, Sells Shares

Kumar Budur, Chief Medical Officer of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY), filed a Form 4 on September 18, 2026, disclosing stock option exercises and sales of common stock across three trading days from September 16 through September 18, 2026.

Aakashdeep | 18 September 2026

Clover Health CEO Sells 1,921 Shares Under 10b5-1 Plan

A Form 4 filed with the SEC on September 18, 2026, discloses that Jamie L. Reynoso, CEO of Medicare Advantage at Clover Health Investments, Corp. /DE (NASDAQ:CLOV), sold 1,921 shares of Class A Common Stock on September 17, 2026, under a pre-established Rule 10b5-1 …

Manish Choudhary | 18 September 2026

Inhibrx Biosciences Director Receives Amended Stock Option Grant

An amended beneficial ownership statement for Inhibrx Biosciences, Inc. (NASDAQ:INBX) director Kristiina Vuori, MD, was filed on September 18, 2026, restating a June 4, 2026 original filing to correct the number of stock options granted due to an administrative error.

Aakashdeep | 18 September 2026

Inhibrx Biosciences Director Stock Option Grant Corrected

An amended ownership statement for Douglas Forsyth, a director at Inhibrx Biosciences, Inc. (NASDAQ:INBX), was filed on September 18, 2026, restating a June 4, 2026 original to correct the number of stock options reported due to an administrative error.

Shwetambri Chauhan | 18 September 2026
Support

Hi! How can we help you today?

Loading…